A deep mutational pharmacology approach is developed to measure how each residue in the µ-opioid receptor (µOR) shapes responses to 15 opioids, yielding ∼400,000 measurements of variant effects on signaling and expression, including full concentration-response series for three agonists.
Matthew K. Howard, Eve J. Fine, Karthik Srinivasan et al.· bioRxiv· 1 citation
Cryo-electron microscopy structures of apo, agonist-bound, and antagonist-bound GerA reveal a symmetric pentamer of heterotrimers that connects nutrient binding to pore opening in this new class of ligand-gated ion channels.
Joshua C. Cofsky, Fernando H. Ramírez-Guadiana, Briana L. Sobecks-Doherty et al.· bioRxiv· 0 citations
Structural and computational analyses reveal that inhibition and isoform selectivity are anchored by interactions with a conserved lysine, with surrounding binding-site residues subtly tuning the local electrostatic environment to promote or disfavor these contacts.
Chih-Ta Chien, Briana L. Sobecks-Doherty, A. Powers et al.· Proceedings of the National...· 0 citations
The DNA- encoded library screening-guided isolation and pharmacological characterization of the first small molecule AT1R allosteric ligands are reported, uncovering new mechanisms for precisely controlling the dynamic behavior of the AT1R with implications for drug development targeting this pathophysiologically impor...
Samuel Liu, Peng Xiao, M. Elgeti et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.